Feline panleukopenia virus and canine parvovirus: development of two qPCR assays with high-resolution melting analysis and molecular epidemiology in dogs and cats from Northen Italy in 2017–2023

The <i>Protoparvovirus carnivoran</i> 1 viral species includes relevant pathogens as feline panleukopenia virus (FPV) and canine parvovirus type 2 (CPV-2), which are mainly responsible for immunosuppression and gastroenteritis in domestic and wild carnivores. Differently to FPV, CPV is frequently subjected to mutations. To date, the original antigenic type CPV-2 is mainly used in vaccine production, while field strains have been progressively replaced by the CPV antigenic variants 2a, 2b, and 2c. In recent years, additional distinctive mutations have been identified in different CPV antigenic variants classified as "Asian-like." The variability of these viruses can impact on the reliability of molecular diagnostic tests potentially leading to false-negative results or delays in diagnosis. To improve diagnostic accuracy and efficiency, innovative molecular techniques such as High-Resolution Melting (HRM) analysis have been developed. These methods reduce execution time, facilitate diagnosis, and enable the differentiation of species or variants without the need for sequencing. In this study, two real-time PCR (qPCR) assays with HRM analysis were developed to complement existing tools for the detection and genetic differentiation of circulating FPV and CPV. Specifically, a test capable of differentiating FPV, original CPV-2 and CPV-2 antigenic variants, and a test for the identification of Asian-like CPV strains were validated. Furthermore, the FPV and CPV-2 identified in 33 dogs and cats diagnosed with parvoviral infection in a veterinary teaching hospital in Northern Italy between 2017 and 2023 were genetically characterized by sequencing. Based on specific VP2 amino acid residues, 33.3% viruses were FPV, 6.1% were original CPV-2, 6.1% were CPV-2a, 21.2% were CPV-2b and 33.3% were CPV-2c. FPV were detected only in cats and showed high amino acid similarity, confirming its evolutionary stasis. The 45.4% of CPV identified in this study, carried amino acid residues resembling those of Asian-like viruses, suggesting an origin linked to an initial importation and subsequent local diffusion. In contrast, the other CPV-2a, 2b, and 2c viruses exhibited greater genetic heterogeneity and their autochthonous origin was supposed. The two qPCR-HRM assays successfully detected and classified all the FPV and CPV tested, highlighting their reliability and usefulness for both diagnostic and epidemiological purposes.

Authors

Institutions

Publication Details

Journal
Frontiers in Veterinary Science
Published
2026-03-04
DOI
https://doi.org/10.3389/fvets.2026.1789452
Primary Topic
Virus-based gene therapy research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Feline panleukopenia virus and canine parvovirus: development of two qPCR assays with high-resolution melting analysis and molecular epidemiology in dogs and cats from Northen Italy in 2017–2023

Lorenza Urbani, M. F. Magliocca, L. Gallina, M. Battilani et al.
Frontiers in Veterinary Science
Virus-based gene therapy research
article

Feline panleukopenia virus and canine parvovirus: development of two qPCR assays with high-resolution melting analysis and molecular epidemiology in dogs and cats from Northen Italy in 2017–2023

Lorenza Urbani, M. F. Magliocca, L. Gallina, M. Battilani, Veronica Facile, Andrea Balboni, Maddalena Vigato
article en

Abstract

The <i>Protoparvovirus carnivoran</i> 1 viral species includes relevant pathogens as feline panleukopenia virus (FPV) and canine parvovirus type 2 (CPV-2), which are mainly responsible for immunosuppression and gastroenteritis in domestic and wild carnivores. Differently to FPV, CPV is frequently subjected to mutations. To date, the original antigenic type CPV-2 is mainly used in vaccine production, while field strains have been progressively replaced by the CPV antigenic variants 2a, 2b, and 2c. In recent years, additional distinctive mutations have been identified in different CPV antigenic variants classified as "Asian-like." The variability of these viruses can impact on the reliability of molecular diagnostic tests potentially leading to false-negative results or delays in diagnosis. To improve diagnostic accuracy and efficiency, innovative molecular techniques such as High-Resolution Melting (HRM) analysis have been developed. These methods reduce execution time, facilitate diagnosis, and enable the differentiation of species or variants without the need for sequencing. In this study, two real-time PCR (qPCR) assays with HRM analysis were developed to complement existing tools for the detection and genetic differentiation of circulating FPV and CPV. Specifically, a test capable of differentiating FPV, original CPV-2 and CPV-2 antigenic variants, and a test for the identification of Asian-like CPV strains were validated. Furthermore, the FPV and CPV-2 identified in 33 dogs and cats diagnosed with parvoviral infection in a veterinary teaching hospital in Northern Italy between 2017 and 2023 were genetically characterized by sequencing. Based on specific VP2 amino acid residues, 33.3% viruses were FPV, 6.1% were original CPV-2, 6.1% were CPV-2a, 21.2% were CPV-2b and 33.3% were CPV-2c. FPV were detected only in cats and showed high amino acid similarity, confirming its evolutionary stasis. The 45.4% of CPV identified in this study, carried amino acid residues resembling those of Asian-like viruses, suggesting an origin linked to an initial importation and subsequent local diffusion. In contrast, the other CPV-2a, 2b, and 2c viruses exhibited greater genetic heterogeneity and their autochthonous origin was supposed. The two qPCR-HRM assays successfully detected and classified all the FPV and CPV tested, highlighting their reliability and usefulness for both diagnostic and epidemiological purposes.

Frontiers in Veterinary ScienceVol. 13
University of Bologna (IT)
European Commission
Good health and well-being
Openalex Percentile: Top 35%
Virus-based gene therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.